Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agentsManujendra N. Saha(University of Toronto), Hong Chang(University of Toronto)British Journal of CancerApril 1, 201410.1038/bjc.2014.164Cited by 44SaveCiteExport RISWatch citationsRelated PapersTargeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma|PLoS ONE|2012|80Anti‑Axl monoclonal antibodies attenuate the migration of MDA‑MB‑231 breast cancer cells|Oncology Letters|2021|10